Developmental Hypothyroidism: An Underappreciated Risk Factor of Brain Barrier Disruption
On this page:
Exposure to environmental thyroid disrupting chemicals is a concern for pregnant women and children as thyroid hormone (TH) action controls brain development. Recently, through RNA-sequencing (RNA-seq) and confocal microscopy, we showed that the blood-brain and blood-cerebrospinal fluid barriers may be affected in newborn rats with moderate hypothyroidism. This is consistent with what is observed in adult hypothyroid patients, where brain barrier function is compromised but rescued by TH supplementation. Thus, brain barrier function may be an overlooked target of endocrine disrupting chemicals. To address if TH action controls the development and/or function of the brain barriers, we gavaged pregnant rats with 0 or 0.875 mg/kg/day propylthiouracil (PTU) from gestational day (GD) 6 to postnatal day (PN) 14. This exposure significantly reduced dam and pup serum T4 and T3 during the first 2 postnatal weeks. Pup brain T4 and T3 were also significantly reduced. On PN8 we isolated pup choroid plexus (blood-cerebrospinal fluid barrier) and performed RNA-Seq. We detected 1102 differently expressed genes (DEGs) in the choroid plexus of PTU exposed animals as compared to controls (q<0.05). Five different claudins (tight junction proteins) were altered in the choroid plexus, including downregulation of claudin-5, which maintains brain barrier occluding activity. Gene Ontology analyses of the DEGs showed enrichment for the following biological processes: oxidative phosphorylation, ATP metabolic process, and cellular respiration. Ingenuity Pathway Analysis showed similar enrichment patterns, and also indicated increased oxidative stress and apoptosis. To investigate the functionality of the brain barriers, in vivo permeability assays were conducted using NHS-EZ-link biotin (443 Da). These experiments show that following cardiovascular perfusion, extraversion of the biotin marker into the brain parenchyma was observed in PTU exposed animals, while controls maintained this tracer within the brain’s vasculature. In summary, these data show that developmental hypothyroidism affects the transcriptome of the blood-cerebrospinal fluid barrier and the function of the blood-brain barrier. Thus, not only could environmental thyroid disrupting chemicals target the brain barriers, but a fetus, infant, and/or child with thyroid dysfunction may be more susceptible to other neurotoxicants due to increased barrier permeability. This work does not reflect US EPA policy.